India Ventilator Market By Equipment Type (Invasive Ventilation, Non-Invasive Ventilation), By Product Type (Adult/Pediatric, Neonatal/Infants), By Mobility (Standalone, Portable), By Mode (Combined Mode, Volume Mode, Pressure Mode, Others), By Source (Domestic, Import), By End User (Hospitals & Clinics, Emergency Medical Services, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Market Overview

The India Ventilator Market size accounted for USD 123.20 Million in 2025 and is predicted to increase from USD 138.43 Million in 2026 to approximately USD 166.62 Million by 2031, expanding at a CAGR of 5.16% from 2026 to 2031.

Key Takeaways

• By equipment type, the invasive ventilation segment accounted for the largest market share, approximately 58% in 2025, owing to its essential role in managing severe respiratory failure, critical illness, and patients requiring controlled and prolonged respiratory support.
• By product type, the Adult/Pediatric segment held the largest market share, approximately 82% in 2025, supported by its broad clinical applicability, versatility across critical-care settings, and ability to accommodate a larger patient population compared with specialized neonatal systems.
• By mobility, the Standalone segment emerged as the leading contributor, accounting for approximately 76% market share in 2025, driven by its suitability for continuous bedside ventilation, established ICU usage, broad functionality, and compatibility with hospital critical-care infrastructure.
• By mode, the Combined Mode segment accounted for the largest market share, approximately 40% in 2025, supported by its ability to integrate multiple ventilation approaches, provide greater clinical flexibility, and accommodate changing patient requirements throughout respiratory therapy.
• By source, the Domestic segment held the largest market share, approximately 61% in 2025, supported by growing adoption of locally manufactured medical devices, cost competitiveness, localized technical support, and increasing availability of domestically developed ventilator technologies.
• By region, South India accounted for the largest market share, approximately 30% in 2025, supported by its concentration of tertiary and super-specialty hospitals, established critical-care infrastructure, specialist healthcare facilities, and relatively strong adoption of advanced medical technologies.
• Rising respiratory disease burden, expansion of critical-care infrastructure, increasing healthcare investment, technological advancement in ventilators, growing adoption of portable and connected systems, and continued development of domestic medical-device manufacturing are expected to drive the long-term growth of the India Ventilator Market.

Market Drivers

Rising Burden of Respiratory Diseases

The rising burden of chronic and acute respiratory diseases is a key growth driver for the India ventilator market. According to the WHO’s 2025 South-East Asia regional report, India accounted for approximately 66.8 million chronic respiratory disease cases in 2021, including 35.8 million COPD cases and 32.1 million asthma cases. A 2026 systematic review and meta-analysis further estimated the pooled prevalence of COPD among Indian adults at 13%, rising to 27% among adults aged 60 years and above. The substantial respiratory disease burden, compounded by air pollution and tobacco exposure, is expected to increase demand for invasive and non-invasive ventilatory support across ICUs, emergency departments, and critical-care facilities.

Expansion of ICU and Critical-Care Infrastructure

Expansion of intensive-care and emergency-care infrastructure is strengthening demand for ventilators across India. Under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PM-ABHIM), 621 Critical Care Blocks (CCBs) had been approved and sanctioned by December 2025, with these facilities designed to include well-equipped ICUs and oxygen-supported beds. The Union Budget 2026–27 further allocated ₹4,770 crore to PM-ABHIM, representing a 67.66% increase over the previous revised estimate, to expand critical-care blocks, district hospitals and related infrastructure. This continued investment in district-level critical care, alongside expansion of tertiary hospitals and emergency services, is expected to increase procurement of invasive and non-invasive ventilators.

Post-COVID Focus on Critical-Care Preparedness

The COVID-19 pandemic significantly strengthened India’s focus on critical-care preparedness and respiratory-support capacity, creating a sustained requirement for ventilators. In December 2021, the Government reported 63,773 ventilator-equipped ICU beds across 23,665 dedicated COVID-19 treatment facilities, highlighting the scale of infrastructure established during the pandemic. In addition, the PM CARES Fund allocated ₹2,000 crore for 50,000 Made-in-India ventilators, accelerating domestic manufacturing capabilities. The government also trained more than 19,000 doctors and paramedical personnel in ventilator operation and maintenance. These investments have increased institutional emphasis on equipment availability, maintenance, and surge capacity, supporting continued ventilator procurement and replacement demand.

Download Free Sample Report

Market Restraints

High Cost of Advanced Ventilator Systems

The high acquisition and lifecycle costs of advanced ventilators remain a restraint, particularly for smaller hospitals and healthcare facilities operating under tight capital budgets. Although domestic manufacturing has reduced prices, the Government of India reported that ventilator costs during the COVID-19 period fell from approximately ₹15 lakh per unit before the pandemic to ₹2–10 lakh as local production expanded. Beyond the initial purchase, hospitals must account for preventive maintenance, calibration, replacement parts, software upgrades, and technical support, increasing total cost of ownership. This challenge is particularly relevant where healthcare providers face constrained budgets and substantial out-of-pocket expenditure. Consequently, cost considerations can delay replacement cycles and limit adoption of premium, technologically advanced ventilators.

Dependence on Imported Components

Dependence on imported components remains a significant restraint for India’s ventilator market, particularly for sophisticated electronic and electro-medical systems. Government data indicate that imports accounted for around 60% of India’s domestic medical-device consumption in FY2024–25. Electro-medical equipment imports alone were valued at approximately US$5.28 billion, while total medical-device imports reached US$8.82 billion during the year. This reliance exposes ventilator manufacturers to exchange-rate fluctuations, international freight costs, supply-chain disruptions, and longer procurement lead times for critical components. Furthermore, limited domestic availability of advanced electronics and specialized components can increase manufacturing costs and constrain the scalability of local production, potentially affecting equipment pricing and replacement cycles.

Infrastructure Requirements Beyond the Ventilator

Ventilator adoption in India can be constrained by gaps in supporting critical-care infrastructure, particularly in lower-resource healthcare facilities. Effective deployment requires reliable electricity, medical-grade oxygen, ICU monitoring systems, infection-control infrastructure, and trained personnel. India’s IPHS dashboard currently lists 209,385 health facilities, of which 77,571 score below 50% against prescribed infrastructure standards, highlighting persistent quality and infrastructure gaps. Government standards specifically require critical areas such as ICUs to have power backup and central oxygen and vacuum supplies. Moreover, the Government’s 2025–26 Annual Report notes that 621 Critical Care Blocks are being established with integrated ICUs, oxygen-supported beds, medical-gas systems, and related infrastructure. These requirements can increase deployment costs and delay procurement where complementary infrastructure is inadequate.

Market Opportunities

Growth of Portable and Home-Care Ventilation

The increasing use of respiratory support outside conventional ICUs presents a significant opportunity for ventilator manufacturers in India. NITI Aayog reported that India’s home healthcare market was valued at approximately US$6.2 billion in 2020 and was projected to reach US$21.3 billion by 2027, creating a broader ecosystem for home-based respiratory services. Government health-technology assessments have also identified low-cost portable ventilators as potentially suitable for long-term ventilation, domiciliary care, emergency settings, and ambulances. This creates opportunities for manufacturers to develop lightweight, battery-operated, user-friendly systems designed for home ventilation, patient transport, post-operative care, and step-down care, thereby expanding ventilator applications beyond hospital-based critical care.

Development of Smart and Connected Ventilators

The shift toward digitally enabled critical care presents an opportunity for Indian ventilator manufacturers to differentiate products through cloud connectivity, remote monitoring, automated ventilation controls, and ICU data integration. Government-backed development has already demonstrated commercial viability: the Technology Development Board supported an indigenous smart ICU ventilator project with ₹3.94 crore in funding against a total project cost of ₹7.89 crore. The resulting system enables connectivity through GSM, Wi-Fi, and LAN, allowing clinicians to remotely monitor patient data and digitise ICU workflows. In addition, the product incorporates advanced capabilities such as automatic closed-loop weaning and metabolic monitoring. Continued adoption of connected-care models could create opportunities for premium ventilators, remote ICU management, and data-driven clinical decision-making.

Demand for Affordable Advanced Ventilation Solutions

The development of affordable ventilators with advanced clinical capabilities represents a significant opportunity in India, particularly for price-sensitive healthcare providers. Government-supported initiatives have demonstrated that locally developed technologies can combine sophisticated functionality with cost competitiveness. The Technology Development Board notes that India has supported the development of affordable, high-end medical devices, including digitally enabled universal ICU ventilators, under its medical-technology commercialization programmes. More recently, the Government reported that domestically manufactured high-end medical devices supported through the PLI scheme are 10–30% cheaper than imported alternatives, indicating potential for competitive local solutions. Manufacturers can capitalize by offering ventilators incorporating advanced monitoring, multiple ventilation modes, and connectivity at accessible price points, particularly for smaller hospitals and emerging healthcare markets.

Market Trends

Shift Toward Multi-Mode Ventilation

The Indian ventilator market is increasingly characterized by a shift toward multi-mode systems capable of supporting diverse clinical requirements across the patient-care pathway. Modern ICU platforms are incorporating invasive and non-invasive ventilation, pressure- and volume-controlled modes, advanced weaning functions, and integrated monitoring within a single device. This trend is reflected in the development of India’s indigenous Noccarc V730i, which incorporates features including automatic closed-loop weaning with PAV, volumetric capnography, metabolic monitoring, and pulse oximetry. Such multifunctional platforms allow clinicians to transition patients between ventilation strategies without changing equipment, while reducing device complexity within ICUs. The trend is consequently moving procurement toward versatile, clinically adaptable ventilators rather than single-purpose systems, particularly in advanced critical-care environments.

Increasing Integration of Digital Monitoring

Increasing integration of digital monitoring is emerging as a notable trend in India’s ventilator market, as manufacturers increasingly incorporate connectivity and data-management capabilities into critical-care devices. Government-supported development of the Noccarc V730i demonstrates this shift, with the ventilator supporting GSM, Wi-Fi, and LAN connectivity for remote monitoring and control by doctors and intensivists. The system can also transmit ventilation data to cloud platforms, enabling centralized ICU visibility and digital documentation. Current product developments further incorporate real-time monitoring, central nursing stations, mobile access, and automated reporting. This trend is gradually positioning ventilators as connected clinical devices rather than standalone respiratory-support equipment, with greater emphasis on interoperability, continuous data availability, and digitally enabled ICU workflows.

Rising Importance of Localized Product Development

India’s ventilator industry is increasingly moving toward localized development of sophisticated life-support equipment, reflecting the broader maturation of the domestic medical-device ecosystem. The Economic Survey 2025–26 confirms that Indian manufacturers now produce high-end devices, including ventilators, while medical-device exports reached US$4.1 billion in FY25, up from US$2.5 billion in FY21. Indian medical devices were exported to 187 countries in FY25, demonstrating expanding international acceptance of domestically manufactured technologies. This trend indicates a transition from basic assembly toward higher-value engineering, product innovation, and manufacturing capabilities. For ventilator manufacturers, increasing localization can support greater control over product design, customization, and technology development while strengthening India’s position within global medical-device supply chains.

Market Report Coverage and Key Metrics

Market Segmentation Analysis

By Equipment Type Insights

Why Did Invasive Ventilation Secure the Largest Share of the India Ventilator Market?

Invasive ventilation is estimated to account for approximately 58% of the India ventilator market, supported by its essential role in managing severe and life-threatening respiratory failure. Its ability to provide controlled, continuous respiratory support makes it particularly important for patients with profound hypoxemia, impaired airway protection, severe respiratory distress, and multi-organ critical illness. Invasive ventilation is also preferred when non-invasive approaches are insufficient or contraindicated, enabling clinicians to maintain a secure airway and precisely regulate ventilation. Its established integration within ICU protocols, compatibility with advanced monitoring systems, and suitability for prolonged critical-care management further reinforce adoption. Consequently, invasive ventilators remain the core equipment category across tertiary-care ICUs and high-acuity critical-care settings.

By Product Type Insights

Why Did Adult/Pediatric Dominate the India Ventilator Market?

Adult/Pediatric ventilators are estimated to account for approximately 82% of the India ventilator market. Their dominance is primarily supported by their broad clinical applicability across adult and pediatric intensive-care settings, allowing hospitals to address a wider patient population with fewer equipment categories. These systems offer multiple ventilation modes and adjustable parameters suited to varying patient conditions, making them appropriate for emergency care, postoperative management, respiratory failure, and prolonged ICU treatment. Their versatility also supports fleet standardization and simplifies procurement, training, and maintenance for hospitals. In addition, modern platforms increasingly combine adult and pediatric capabilities within a single device, improving equipment utilization and operational flexibility. Consequently, Adult/Pediatric systems remain more commercially attractive than specialized neonatal-only ventilators.

By Mobility Insights

Why Did Standalone Dominate the India Ventilator Market?

Standalone ventilators are estimated to account for approximately 76% of the India ventilator market. Their dominance is primarily attributable to their dedicated functionality, established use in critical-care environments, and suitability for continuous bedside ventilation. Standalone systems can provide comprehensive ventilation capabilities without being dependent on integration with other respiratory-support equipment, making them practical for routine ICU deployment. Their compatibility with hospital infrastructure, broad range of ventilation modes, and relatively straightforward installation also support procurement preferences. In addition, standalone platforms can be configured for different patient categories and clinical requirements, allowing hospitals to standardize equipment across critical-care units. Their established clinical workflow integration and suitability for high-acuity, prolonged ventilation further reinforce their position as the preferred mobility category.

By Mode Insights

Why Did Combined Mode Dominate the India Ventilator Market?

Combined Mode is estimated to account for approximately 40% of the India ventilator market. Its leading position is primarily attributed to the clinical flexibility of integrating pressure- and volume-based ventilation approaches, allowing clinicians to adapt respiratory support as patient conditions change. Hybrid modes can help maintain targeted tidal volumes while adjusting pressure according to changing lung mechanics, offering greater control and adaptability than single-mode systems. Their suitability across different stages of mechanical ventilation, including controlled support, assisted breathing, and weaning, further enhances their utility in critical-care settings. Combined Mode also reduces the need to switch between separate ventilation strategies, supporting workflow efficiency and simplifying equipment selection. Consequently, hospitals may favor versatile platforms capable of accommodating diverse patient requirements within a single system.

By Source Insights

Why Did the Domestic Dominate the India Ventilator Market?

Domestic ventilators are estimated to account for approximately 61% of the India ventilator market. Their dominance is supported by the growing acceptance of locally manufactured equipment, particularly where hospitals and public healthcare institutions prioritize cost efficiency, supply continuity, and localized technical support. Domestic products can offer greater customization for Indian clinical and infrastructure requirements while reducing dependence on overseas procurement and associated logistics complexities. Government procurement policies also favor suppliers meeting specified local-content requirements, strengthening the competitive position of domestic manufacturers in institutional tenders. In addition, the expansion of indigenous medical-device capabilities has enabled Indian manufacturers to develop increasingly sophisticated respiratory-care technologies. These factors collectively make domestic ventilators an attractive choice for hospitals seeking cost-effective, serviceable, and locally supported solutions.

Download Free Sample Report

Market Regional Analysis: South India, North India, West India, East India

Why Did South India Lead the India Ventilator Market?

South India is estimated to account for approximately 30% of the India ventilator market, supported by its concentration of advanced tertiary-care hospitals, specialist medical centres, and established critical-care infrastructure. States such as Tamil Nadu, Karnataka, Kerala, Telangana, and Andhra Pradesh have developed strong healthcare ecosystems with extensive private hospital networks and specialized treatment facilities. The region’s concentration of medical colleges and clinical expertise also supports greater availability of trained personnel capable of operating advanced respiratory-support equipment. In addition, major healthcare hubs attract patients from surrounding states and international markets, increasing demand for intensive and emergency care. Stronger adoption of advanced medical technologies, coupled with established referral networks and specialized centres, reinforces South India’s position as a leading market for ventilators.

Why Is South India Expected to Register the Fastest Growth in the India Ventilator Market?

South India is expected to register the fastest growth due to continued development of specialized healthcare capacity, increasing concentration of tertiary and super-specialty services, and expanding medical education infrastructure. The region’s established healthcare ecosystem provides a strong base for adoption of advanced respiratory-care technologies, while ongoing modernization of government medical colleges and hospitals is creating additional opportunities for ventilator deployment. Expansion of specialty departments, critical-care units, and referral hospitals is likely to generate demand for technologically advanced ventilation systems. In addition, the presence of prominent healthcare hubs in Bengaluru, Chennai, Hyderabad, and Kerala supports higher clinical technology adoption and attracts patients requiring complex treatment. The combination of institutional expansion, specialist-care concentration, and improving healthcare accessibility is expected to sustain comparatively rapid ventilator-market growth in the region.

Key Market Players

• Wipro GE Healthcare Pvt. Ltd.
• Skanray Technologies Pvt Ltd
• BPL Medical Technologies Private Limited
• Draeger India Private Limited
• Philips India Limited
• AgVa Healthcare
• ResMed India Private Limited
• Maquet Medical India Pvt Ltd
• Trivitron Healthcare Pvt Ltd
• Narang Medical Limited

Recent Developments

AIIMS New Delhi issued a tender for 10 advanced ICU ventilators in August 2026, specifying integrated metabolic monitoring and automatic closed-loop weaning with proportional assist ventilation (PAV). This indicates increasing institutional demand for technologically advanced ventilation systems.

AIIMS New Delhi also initiated procurement of 40 portable ventilators in August 2026 for various departments, highlighting continued demand for mobility-focused respiratory-support equipment beyond conventional ICU applications.

The Government launched applications under the Scheme for Strengthening of Medical Device Industry (SMDI) in June 2026, including financial support for domestic manufacturing of key components and clinical studies. The initiative is intended to reduce import dependence and deepen domestic medical-device value chains.

Report Scope:

By Equipment Type

• Invasive Ventilation
• Non-Invasive Ventilation

By Product Type

• Adult/Pediatric
• Neonatal/Infants

By Mobility

• Standalone
• Portable

By Mode

• Combined Mode
• Volume Mode
• Pressure Mode
• Others

By Source

• Domestic
• Import

By End User

• Hospitals & Clinics
• Emergency Medical Services
• Others

By Region

• South India
• North India
• West India
• East India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Ventilator Market.

Available Customizations:

India Ventilator market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information